P04580 (ENV_HV1Z6) Human immunodeficiency virus type 1 group M subtype D (isolate Z6) (HIV-1)
Envelope glycoprotein gp160 UniProtKBInterProInteractive Modelling
855 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
9 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| New HIV entry inhibitor MTSFT/T23 complex |
Heteromer | |||||
| Assess | ||||||
| HIV gp41 six-helix bundle containing a mutant CHR alpha-peptide sequence |
Heteromer | |||||
| Assess | ||||||
| HIV gp41 six-helix bundle composed of a chimeric alpha+alpha/beta-peptide analogue of the CHR domai… |
Heteromer | 3×ACE; 12×GOL; | ||||
| Assess | ||||||
| HIV gp41 six-helix bundle composed of an alpha/beta-peptide analogue of the CHR domain in complex w… |
Heteromer | 3×GOL; | ||||
| Assess | ||||||
| Crystal Structure of the broadly neutralizing anti-HIV-1 antibody 2F5 in complex with a gp41 17mer … |
Heteromer | 3×EDO; 6×IPA; | ||||
| Assess | ||||||
| Crystal structure of the neutralizing HIV antibody 2F5 Fab fragment (recombinantly produced Fab) wi… |
Heteromer | |||||
| Assess | ||||||
| Crystal Structure of the broadly neutralizing anti-HIV-1 antibody 2F5 in complex with a gp41 11mer … |
Heteromer | 6×IPA; 2×EDO; | ||||
| Assess | ||||||
| Crystal structure of the neutralizing HIV antibody 2F5 Fab fragment (recombinantly produced IgG) wi… |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of the neutralizing HIV antibody 2F5 Fab fragment (recombinantly produced Fab) wi… |
Heteromer | |||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8eu8.1.A | homo-3-mer | 0.67 | 74.80 | |||
| Assess | ||||||
| 7n6u.1.A | homo-3-mer | 0.57 | 1×NAG; 1×NAG; 3×83G; | 77.69 | ||
| Assess | ||||||